Summary
The product Anavar 10mg, manufactured by Endura Biosciences CO., LTD, underwent independent testing to verify its potency. The sample, identified by batch number 001, was submitted by Endura-Biosciences@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a concentration of 10.97 mg, which is 9.7% above the labeled claim of 10 mg.
The testing process was conducted on 15 July 2024. While the results confirm overdosing, scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Endura Biosciences CO. LTD
- Product Name: Anavar 10mg
- Active Ingredient: Oxandrolone
- Batch Number: 001
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #45349
- ClientTesting Ordered: 4 July 2024
Sample Received: 12 July 2024 - Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Specification: 10 mg (as stated on the label)
- Measured Concentration: 10.97 mg
- Accuracy: 109.7% (9.7% above the label claim)
- Variance: 9.7
Verification Details
- Verification URL: https://janoshik.com/tests/45349_GV42WSMBRVE9
Evaluation of Reseller-Submitted Testing
This analysis highlights the overdosing of the tested product but warrants careful evaluation due to its submission and funding by the client Endura-Biosciences@proton.me. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Anavar 10mg is overdosed, with a measured concentration of 10.97 mg. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
